Microsaic Systems sign exclusive distribution agreement with ST Japan

Microsaic Systems (LON:MSYS), the developer of point of need mass spectrometry instruments, has announced that it has signed an exclusive distribution agreement with ST Japan Inc to distribute Microsaic’s branded 4500 MiD® MS detector in Japan.  The 4500 MiD is a robust and compact MS detector with an integrated computer and vacuum pump, whose small footprint and ease of use make it deployable anywhere within laboratory or processing facilities.

Glenn Tracey, CEO of Microsaic, commented: “I am extremely pleased to partner with ST Japan to distribute our compact, point of need MS technology, alongside their own impressive technology portfolio, and highly relevant list of OEM products, specialising in point of need and remote testing. With a staff of over 40 specialists world-wide, ST Japan has the in-depth technical expertise, and full reach of end user applications, particularly in applications such as at-line reaction monitoring in high-value chemical and pharmaceutical manufacture and field analysis, or “first-responder” and environmental analysis.

“Microsaic has a growing portfolio of partners in North America, Europe, China, Korea, SE Asia, Australia and now also Japan.  This is a well-established market for analytical chemistry, and this latest agreement with ST Japan marks another milestone in what we expect to be a very exciting period of growth in international deployments of Microsaic’s technology.”

Established in 1990, and with offices in Japan, the US, Europe and South Korea, ST Japan designs and manufactures its own laboratory equipment and software which it sells world-wide. These include infrared, nuclear magnetic resonance, ultraviolet and Raman analysis equipment and software which has application in multiple markets for chemical and pharmaceutical analysis. ST Japan also distributes OEM equipment for the Japanese market, which includes mobile and portable analysis techniques.

Takao Nakagawa, President of ST Japan, added: “The Microsaic 4500 MiD® is a very interesting addition to our product platform for our domestic market in Japan. We particularly see excellent potential in at-line reaction monitoring applications in a range of markets where industry wants reaction data in real-time and where the cost of batch failure is potentially very high. There is no other MS available which offers this potential in such a compact footprint. We very much look forward to working with Microsaic in the long term.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn

    More articles like this

    Microsaic Systems plc

    VIDEO: Microsaic Systems Investor Presentation 2019

    Microsaic Systems (LON:MSYS) Investor Presentation by Glenn Tracey. Microsaic Systems plc is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry (“MS”) instruments that are designed to improve the efficiency of pharmaceutical R&D and

    Microsaic Systems plc

    Microsaic Systems plc Introduce New Protein Identification Product

    Glenn Tracey, CEO of Microsaic, commented, “Bringing the power of the centralised laboratory to in-situ bioprocessing line measurements, the Microsaic MiD® ProteinID reduces key bioprocessing analyses from days to minutes. This means that operators can monitor

    Microsaic Systems plc

    Advances in Analytics for Bioprocessing

    Richard Moseley, Chief Technologist at Microsaic talks to Biopharma International about process analytical technology (PAT) for monitoring and controlling biopharma production processes. When FDA’s process analytical technology (PAT) initiative was first unveiled, the aim was to

    Microsaic Systems plc

    The need for the miniaturisation of mass spectroscopy

    Microsaic Systems’ Chief Technologist, Richard Moseley, explains the need for miniaturised mass spectrometry, and where the technology can take some key industries such as pharma and biopharma. Arguably the work-horse of most analytical laboratories, mass spectrometry

    Microsaic Systems plc

    Encouraging efficiency

    Encouraging efficiency in pharmaceutical discovery and manufacturing, Microsaic’s Chief Technologist Dr. Richard Moseley discusses chip-based technologies and miniaturisation of mass spectrometry. The current challenges faced by the pharmaceutical industry are nothing new – high costs and

    Microsaic Systems plc

    Innovations in measurement, analysis and testing

    Richard Moseley, Chief Technologist at Microsaic Sytems PLC explains why accurate, timely and efficient measurement techniques are key to optimising production processes in pharmaceutical manufacturing and providing regulators with assurance on product quality. Specialist analytical chemists typically

    MySale Group Plc

    UK retail sees record online spending in 2018

    The latest UK retail report from the Office for National Statistics (ONS), revealed that in the three months to August, the quantity bought increased by 2 percent when compared with the previous three months, with continued

    Microsaic Systems plc

    INTERVIEW: Microsaic Systems 96% Increase in revenues

    Microsaic Systems Plc (LON:MSYS) CEO Glenn Tracey talks to DirectorsTalk about its unaudited interim results for the six months ended 30 June 2018. With a 96% increase in revenues and good operation progress Glenn provides us